Notably, circSMAD2, downregulated in HBV-related HCC serves as a suppressor of tumor growth by sponging miR-629, leading to increased PDCD4 expression which ultimately inhibits EMT (92–94). The gene discussed is PDCD4; the disease is hepatocellular carcinoma.